Pharmacotherapy in patients with vasomotor disorders

C K M Boerhout, R G T Feenstra, T P van de Hoef, J J Piek, M A M Beijk*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Downloads (Pure)

Abstract

BACKGROUND: Anginal symptoms in patients with non-obstructive coronary artery disease are frequently related to vasomotor disorders of the coronary circulation. Although frequently overlooked, a distinct diagnosis of different vasomotor disorders can be made by intracoronary function testing. Early detection and treatment seems beneficial, but little evidence is available for the medical treatment of these disorders. Nevertheless, there are several pharmacotherapeutic options available to treat these patients and improve quality of life.

METHODS & FINDINGS: We performed an extensive yet non-systematic literature search to explore available pharmacotherapeutic strategies for addressing vasomotor disorders in individuals experiencing angina and non-obstructive coronary artery disease. This article presents a comprehensive overview of therapeutic possibilities for patients exhibiting abnormal vasoconstriction (such as spasm) and abnormal vasodilation (like coronary microvascular dysfunction).

CONCLUSION: Treatment of vasomotor disorders can be very challenging, but a general treatment algorithm based on the existing evidence and the best available current practice is feasible.

Original languageEnglish
Article number101267
Number of pages9
JournalIJC Heart and Vasculature
Volume48
DOIs
Publication statusPublished - Oct 2023

Keywords

  • ANOCA
  • Abnormal vasodilation
  • Coronary function testing
  • Pharmacotherapy
  • Vasospams

Fingerprint

Dive into the research topics of 'Pharmacotherapy in patients with vasomotor disorders'. Together they form a unique fingerprint.

Cite this